BIS said OTC derivatives value rose to $21 trillion between June and December 2014
By Edward Lopez, Vice President, EMEA at
In the world of fashion, they say trends from years ago always
come back. Well, the same is true in the not quite so glamorous
market of over the counter (OTC) derivatives. Seven years after
the crisis, the same contracts once more vilified than a
Supermodel’s waist size are once again the talk of
the street – that’s Wall Street not the
This article is available to subscribers and registered users
Please log in to continue reading.
Not yet registered? Take a free trial.
If you have already taken a free trial you
have ongoing access to the analysis section of FOW.com including this story.
Log in using your details below to read.
Already have an account? |